CClinicalTrials.gg
CompletedNCT07514299Updated Apr 7, 2026

Investigation of the Effects of Pre-Angiography Music Interview and Aromatherapy Application on Pain, Anxiety, Fear, and Comfort Levels in Cardiology Patients

An interventional study of Lavender essential oil inhalation and Music intervention in Cardiology and Angiography, sponsored by Istanbul Aydın University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by Istanbul Aydın University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Nov 2024, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
139
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study was conducted to examine the effects of non-pharmacological interventions applied before coronary angiography in cardiology patients. Specifically, the study focused on the use of music listening and lavender oil inhalation and their potential impact on patients' psychological and physical states prior to the procedure. The research was designed as a randomized controlled experimental study, in which participants were assigned to intervention and control groups for comparison.

Within the scope of the study, pain, anxiety, fear, and comfort levels were evaluated using standardized measurement tools, and data were collected through pre- and post-intervention assessments. The study emphasizes the importance of integrating complementary methods into clinical practice within a holistic nursing care approach.

Overall, the study aims to provide scientific evidence regarding the applicability of music therapy and aromatherapy as supportive, non-pharmacological interventions in the pre-angiography care of cardiology patients.

02

Conditions studied

  • Cardiology
  • Angiography

Keywords

  • Cardiology
  • Music
  • Aromatherapy
03

In context

Lead sponsor

Istanbul Aydın University is the lead sponsor of 65 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • No sedation before or during angiography
  • No diagnosed psychiatric disorder
  • Normal sense of smell
  • No allergy to essential oils used
  • Voluntary participation
  • Scheduled for angiography within 24 hours
  • Independent in activities of daily living
  • Literate (able to read and write)
  • No hearing impairment
  • Able to communicate effectively
  • No respiratory disease (e.g., asthma, COPD)
  • Not using non-pharmacological methods (e.g., yoga, reiki

Exclusion criteria

Exclusion Criteria:

  • Communication problems
  • Psychiatric disorder diagnosis
  • Allergy to essential oils
  • Impaired sense of smell
  • Dislike or discomfort with lavender scent
  • Refusal to participate
  • Respiratory disease (e.g., asthma, COPD)
  • Peripheral vascular disease
  • Neurological disorder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
139 participants (actual)

Study arms

  • Experimental
    Experimental (Lavender) Group

    Patients in the aromatherapy group received lavender essential oil inhalation therapy, in which three drops of lavender oil were applied to a sterile sponge and held approximately 5 cm from the patient's nose for 5 minutes. This distance was maintained to ensure standardization of the intervention.

    Other: Lavender essential oil inhalation

  • Experimental
    Experiment (Music) Group

    Patients in the music intervention group listened to relaxing classical music through headphones for 10 minutes in the waiting area before the angiography procedure.

    Other: Music intervention

  • Other
    Control Group

    Participants in the control group received routine care without any additional intervention.

    Other: routine care

Interventions

  • OtherLavender essential oil inhalation

    Patients in the aromatherapy group received lavender essential oil inhalation therapy, in which three drops of lavender oil were applied to a sterile sponge and held approximately 5 cm from the patient's nose for 5 minutes.

  • OtherMusic intervention

    Patients in the music intervention group listened to relaxing classical music through headphones for 10 minutes in the waiting area before the angiography procedure.

  • Otherroutine care

    Routine care before angiography includes patient assessment, ensuring fasting, establishing intravenous access, adjusting medication, and preparing the patient physically and psychologically for the procedure.

06

What researchers measure

Primary outcomes

  1. Patient Information Form

    The Patient Information Form was developed by the researchers based on an extensive review of the literature. The form included questions designed to collect information about the socio-demographic and clinical characteristics of the participants. The variables included in the form were age, gender, education level, marital status, place of residence, income level, smoking status, presence of chronic disease, previous angiography experience, and other relevant health-related information.

    Time frame: First day

  2. General Comfort Scale

    The scale is designed based on a taxonomic structure that includes three levels and four dimensions forming the theoretical components of comfort, and is used to determine needs and to evaluate the extent to which comfort-providing nursing interventions lead to an increase in expected comfort. The scale is a four-point Likert type and contains a total of 48 items. The response patterns of the scale, which consists of positive and negative items, are given in a mixed order. Accordingly, a high score (4) in positive items indicates high comfort, and a low score (1) indicates low comfort. In the evaluation of the scale, the obtained negative scores are reverse-coded and added to the positive items. The highest total score that can be obtained from the scale is 192, and the lowest total score is 48.

    Time frame: First day

  3. General Comfort Scale

    The scale is designed based on a taxonomic structure that includes three levels and four dimensions forming the theoretical components of comfort, and is used to determine needs and to evaluate the extent to which comfort-providing nursing interventions lead to an increase in expected comfort. The scale is a four-point Likert type and contains a total of 48 items. The response patterns of the scale, which consists of positive and negative items, are given in a mixed order. Accordingly, a high score (4) in positive items indicates high comfort, and a low score (1) indicates low comfort. In the evaluation of the scale, the obtained negative scores are reverse-coded and added to the positive items. The highest total score that can be obtained from the scale is 192, and the lowest total score is 48.

    Time frame: Second day

  4. Visual Analog Scale for Pain

    The VAS, developed by Price et al. (1983), is commonly used in research to assess the intensity of pain as experienced by patients. It is a reliable and valid instrument. The scale consists of a 10-cm line, which can be either horizontal or vertical, with one end marked as "No Pain" (0) and the other as "Worst Pain" (10). Patients are given clear instructions on how to use the VAS and are asked to mark the point on the line that best represents their level of pain. The distance from the "No Pain" end to the patient's mark is then measured in centimeters and recorded. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain.

    Time frame: First day

  5. Visual Analog Scale for Pain

    The VAS, developed by Price et al. (1983), is commonly used in research to assess the intensity of pain as experienced by patients. It is a reliable and valid instrument. The scale consists of a 10-cm line, which can be either horizontal or vertical, with one end marked as "No Pain" (0) and the other as "Worst Pain" (10). Patients are given clear instructions on how to use the VAS and are asked to mark the point on the line that best represents their level of pain. The distance from the "No Pain" end to the patient's mark is then measured in centimeters and recorded. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain.

    Time frame: Second day

  6. Visual Analog Scale for Fear

    Fear levels were measured using a similar Visual Analog Scale, ranging from 0 to 10, where 0 indicates "no fear" and 10 represents "extreme fear". Participants were asked to mark the point on the scale that best represented their fear level before the angiography procedure.

    Time frame: First day

  7. Visual Analog Scale for Fear

    Fear levels were measured using a similar Visual Analog Scale, ranging from 0 to 10, where 0 indicates "no fear" and 10 represents "extreme fear". Participants were asked to mark the point on the scale that best represented their fear level before the angiography procedure.

    Time frame: Second day

  8. Visual Analog Scale for Anxiety

    Participants' anxiety levels were also measured using a Visual Analog Scale ranging from 0 (no anxiety) to 10 (extreme anxiety). The scale allows patients to subjectively evaluate the severity of their anxiety at the time of assessment.

    Time frame: First day

  9. Visual Analog Scale for Anxiety

    Participants' anxiety levels were also measured using a Visual Analog Scale ranging from 0 (no anxiety) to 10 (extreme anxiety). The scale allows patients to subjectively evaluate the severity of their anxiety at the time of assessment.

    Time frame: Second day

  10. State-Trait Anxiety Inventory

    The State Anxiety Scale is a highly sensitive tool for assessing rapidly changing emotional reactions. It provides information about an individual's operational anxiety. It is a four-point scale ranging from "none" to "completely." The Trait Anxiety Scale, on the other hand, requires the individual to describe how they generally feel. The State Anxiety Scale includes both direct and inverted statements. Direct statements indicate negative emotions, while inverted statements indicate positive emotions. The final value obtained is the individual's anxiety score. In interpreting the scores, the total score obtained from both inventories ranges from 20 to 80. A high score indicates a high level of anxiety, while a low score indicates a low level of anxiety.

    Time frame: First day

  11. State-Trait Anxiety Inventory

    The State Anxiety Scale is a highly sensitive tool for assessing rapidly changing emotional reactions. It provides information about an individual's operational anxiety. It is a four-point scale ranging from "none" to "completely." The Trait Anxiety Scale, on the other hand, requires the individual to describe how they generally feel. The State Anxiety Scale includes both direct and inverted statements. Direct statements indicate negative emotions, while inverted statements indicate positive emotions. The final value obtained is the individual's anxiety score. In interpreting the scores, the total score obtained from both inventories ranges from 20 to 80. A high score indicates a high level of anxiety, while a low score indicates a low level of anxiety.

    Time frame: Second day

07

Study locations

1 site
  • Istanbul Aydin University
    Istanbul, Istanbul 34295, Turkey (Türkiye)
08

References and documents

Publications

  • Amin, A., Amraei, M., Shahijan, M., Nadri, S., & Moradifar, N. (2021). The effects of aromatherapy on patients undergoing coronary angiography: A systematic review of clinical trials. Journal of Herbmed Pharmacology, 11(1), 1-9. https://doi.org/10.34172/jhp.2022.01 Auliya, K., Suryani, R., & Yudha, M. (2024). Implementasi Aromaterapi Mawar Untuk Mengurangi Kecemasan Pre Operasi Pada Pasien Sectio Caesarea Dengan Anestesi Spinal. Kolaborasi Jurnal Pengabdian Masyarakat, 4(5), 364-372. https://doi.org/10.56359/kolaborasi.v4i5.408 Borges, A. (2025). Lavender, Peppermint, Neroli, and Eucalyptus in the Modulation of Pain and Anxiety: A Critical Review of Aromatherapeutic Approaches. Brazilian Journal of Health Aromatherapy and Essential Oil, 2(1), bjhae24. https://doi.org/10.62435/2965-7253.bjhae.2025.bjhae24 Devi, S., Agustini, T., & Taqiyah, Y. (2023). Aromaterapi Lavender dalam Menurunkan Tingkat Kecemasan Pasien Pre Operasi Sectio Caesarea. Window of Nursing Journal, 153-159. https://doi.org/10.33096/won.v4i2.521 Dwitanta, S. (2024). AROMA THERAPY INTERVENTION TO IMPROVING SLEEP QUALITY IN PATIENTS WITH CARDIOVASCULAR PROBLEMS. Jurnal Keperawatan Malang, 9(2), 130-139. https://doi.org/10.36916/jkm.v9i2.271 Eslami, J., Ebrahimi, A., Hosseinkhani, A., Khazaei, Z., & Darvishi, I. (2018). The effect of aromatherapy using Lavender (Lavandula angustifolia Miller) and Citrus aurantium L. extracts to treat anxiety of patients undergoing laparoscopic cholecystectomy: A randomized clinical trial in Iran. Biomedical Research and Therapy, 5(3), 2096-2110. https://doi.org/10.15419/bmrat.v5i3.423 Eğilmez, O., Güven, M., Yılmaz, A., Güven, E., & Gündoğan, M. (2021). Investigation of the Effects of Lavender Oil Aromatherapy to Prevent Preoperative Anxiety in Patients Scheduled for Tympanoplasty. International J

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07514299
Lead sponsor
Istanbul Aydın University
Collaborators
Cyprus Aydin University
Responsible party
DİLEK YILDIRIM (Assoc. Prof. Dr., Istanbul Aydın University) — Principal investigator
First posted
Apr 7, 2026
Start date
Nov 1, 2024
Primary completion
Dec 30, 2025
Completion
Jan 30, 2026
Last update
Apr 7, 2026

Study contacts

İNCİHAN KARAMAN, MsC
principal investigator · Cyprus Aydin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion